ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,787.26
-0.01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Hollis-Eden Pharmaceuticals (MM) (HEPH)

  7. Hollis-Eden Pharmaceuticals (MM) (HEPH) News

Hollis-Eden Pharmaceuticals (MM) (HEPH)

Hollis-Eden Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HEPH
DateTimeSourceHeadlineSymbolCompany
17/02/201021:03PR Newswire (US)Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR'NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
16/02/201021:27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201019:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201019:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201019:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201019:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201019:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201019:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201019:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
06/01/201021:31Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
22/12/200921:38Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/12/200911:03Edgar (US Regulatory)Securities Registration (section 12(b)) (8-A12B)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
16/11/200914:00PR Newswire (US)Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular TaNASDAQ:HEPH
12/11/200921:37PR Newswire (US)Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and CancerNASDAQ:HEPH
06/11/200922:23Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
22/10/200911:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
20/10/200914:11PR Newswire (US)Hollis-Eden Pharmaceuticals Retains Burrill LLC to Provide Exclusive Advisory Services for Lead ProgramsNASDAQ:HEPH
16/09/200918:33Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
16/09/200913:30PR Newswire (US)Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid PriceNASDAQ:HEPH
14/08/200911:06Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/06/200920:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/06/200917:30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/06/200912:05PR Newswire (US)Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEONASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
11/06/200921:54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
05/06/200921:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
14/05/200911:03Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
07/05/200922:00Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
23/04/200922:00Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
31/03/200922:36Business WireHollis-Eden Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial ResultsNASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
31/03/200922:30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:HEPH

Your Recent History

LSE
PET
Petrel Resources
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
GKP
Gulf Keystone Petroleum
LSE
POS
Plexus
LSE
OXB
Oxford Biomedica
LSE
SCLP
Scancell
LSE
AGL
Angle
LSE
PANR
Pantheon Resources
LSE
ITV
Itv
LSE
SCE
Surface Transforms
LSE
GOLD
LSE
SYME
Supply@me Capital
LSE
SRSP
Sirius Petroleum
LSE
ENET
Ethernity Networks
LSE
TXP
Touchstone Exploration
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved